Delphi method to determine a list of questionnaire-assessed parameters in the follow-up of patients with inflammatory bowel disease

Abstract

BACKGROUND: Patients with inflammatory bowel disease often require lifelong follow-up by a clinician. Telemedicine monitoring is a promising area of such healthcare services, often based on the evaluation of patients’ remote questionnaire results by a medical practitioner.

AIM: To define, using the Delphi method, a list of questionnaire-assessed parameters for monitoring and treating patients with IBD.

MATERIALS AND METHODS: The study was conducted in three stages. An electronic survey form was created to collect information, ensuring that the respondent’s experience was included when completing the survey. In the first stage, respondents answered an open-ended question about what parameters assessed by questionnaires should be monitored in patients with IBD. In the second stage, participants answered the same question but selected any number of items from a list. In the third stage, the responses were analyzed. The primary endpoint was a consensus on each parameter, defined as >75% respondent agreement.

RESULTS: The study had 15 participants, 13.3% of whom were male. Of all respondents, 46% worked in an outpatient setting, whereas 54% worked in an inpatient setting. Their ages ranged from 25 to 53 years, with 53% of the participants having 1–4 years of experience and 47% having 17–29 years of experience. None of the parameters reached a 75% agreement level based on the results of the first stage. In the second stage, respondents reached a consensus on 72% of the parameters. No relationship was found between respondents’ age, sex, years of experience, or job settings and responses in the first and second stages.

CONCLUSIONS: The final list of parameters recommended for evaluation during the monitoring and treatment of patients with IBD included abdominal pain, frequency of defecation and stool quality, presence of pathological stool impurities, body temperature, joint/muscle pain, sleep quality, anxiety, depression, work capacity for employed/ability to attend lessons for students, energy and quantity of vigor, fixation on the disease, patients’ general evaluation of their quality of life, and treatment adherence.

Keywords

Delphi method / quality of life / disability evaluation / medication adherence / inflammatory bowel diseases

References

[1] Romberg-Camps MJL, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease. Inflammatory Bowel Diseases. 2010;16(12):2137–2147. doi: 10.1002/ibd.21285

[2] Romberg-Camps M.J.L., Bol Y., Dagnelie P.C., et al. Fatigue and health-related quality of life in inflammatory bowel disease // Inflammatory Bowel Diseases. 2010. Vol. 16, N 12. P. 2137–2147. doi: 10.1002/ibd.21285

[3] Romberg-Camps MJL, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease. Inflammatory Bowel Diseases. 2010;16(12):2137–2147. doi: 10.1002/ibd.21285

[4] Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Current Gastroenterology Reports. 2019;21(8. doi: 10.1007/s11894-019-0705-6

[5] Windsor J.W., Kaplan G.G. Evolving Epidemiology of IBD // Current Gastroenterology Reports. 2019. Vol. 21, N 8. doi: 10.1007/s11894-019-0705-6

[6] Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Current Gastroenterology Reports. 2019;21(8. doi: 10.1007/s11894-019-0705-6

[7] Khalif IL, Shapina MV. Inflammatory bowel disease treatment in Eastern Europe. Current Opinion in Gastroenterology. 2017;33(4):230–233. doi: 10.1097/mog.0000000000000370

[8] Khalif I.L., Shapina M.V. Inflammatory bowel disease treatment in Eastern Europe // Current Opinion in Gastroenterology. 2017. Vol. 33, N 4. P. 230–233. doi: 10.1097/mog.0000000000000370

[9] Khalif IL, Shapina MV. Inflammatory bowel disease treatment in Eastern Europe. Current Opinion in Gastroenterology. 2017;33(4):230–233. doi: 10.1097/mog.0000000000000370

[10] Belousova EA, Shelygin YuA, Achkasov SI, et al. Clinical and Demographic Features and Treatment Approaches for Inflammatory Bowel Diseases (Crohn’s Disease, Ulcerative Colitis) in the Russia. The Primery Results of the Analysis of the National Register. Koloproktologia. 2023;22(1):65–82. (In Russ) doi: 10.33878/2073-7556-2023-22-1-65-82

[11] Белоусова E.A., Шелыгин Ю.А., Ачкасов С.И., и др. Клинико-демографические характеристики и лечебные подходы у пациентов с воспалительными заболеваниями кишечника (болезнь Крона, язвенный колит) в РФ. Первые результаты анализа национального Регистра // Колопроктология. 2023. Т. 22, № 1. С. 65–82. doi: 10.33878/2073-7556-2023-22-1-65-82

[12] Belousova EA, Shelygin YuA, Achkasov SI, et al. Clinical and Demographic Features and Treatment Approaches for Inflammatory Bowel Diseases (Crohn’s Disease, Ulcerative Colitis) in the Russia. The Primery Results of the Analysis of the National Register. Koloproktologia. 2023;22(1):65–82. (In Russ) doi: 10.33878/2073-7556-2023-22-1-65-82

[13] Pang L, Liu H, Liu Zh, et al. Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Medical Internet Research. 2022;24(3):e28978. doi: 10.2196/28978

[14] Pang L., Liu H., Liu Zh., et al. Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials // Journal of Medical Internet Research. 2022. Vol. 24, N 3. P. e28978. doi: 10.2196/28978

[15] Pang L, Liu H, Liu Zh, et al. Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Medical Internet Research. 2022;24(3):e28978. doi: 10.2196/28978

[16] Trieschmann K, Chang L, Park S, et al. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease. Neurogastroenterology & Motility. 2022;34(9). doi: 10.1111/nmo.14384

[17] Trieschmann K., Chang L., Park S., et al. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease // Neurogastroenterology & Motility. 2022. Vol. 34, N 9. doi: 10.1111/nmo.14384

[18] Trieschmann K, Chang L, Park S, et al. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease. Neurogastroenterology & Motility. 2022;34(9). doi: 10.1111/nmo.14384

[19] Jackson BD, Con D, Gorelik A, et al. Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort. Internal Medicine Journal. 2018;48(10):1234–1241. doi: 10.1111/imj.13937

[20] Jackson B.D., Con D., Gorelik A., et al. Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort // Internal Medicine Journal. 2018. Vol. 48, N 10. P. 1234–1241. doi: 10.1111/imj.13937

[21] Jackson BD, Con D, Gorelik A, et al. Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort. Internal Medicine Journal. 2018;48(10):1234–1241. doi: 10.1111/imj.13937

[22] Thomas PWA, Broeder N, Derikx M, et al. Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study. Inflammatory Bowel Diseases. 2022;28(12):1813–1820. doi: 10.1093/ibd/izac002

[23] Thomas P.W.A., Broeder N., Derikx M., et al. Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study // Inflammatory Bowel Diseases. 2022. Vol. 28, N 12. P. 1813–1820. doi: 10.1093/ibd/izac002

[24] Thomas PWA, Broeder N, Derikx M, et al. Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study. Inflammatory Bowel Diseases. 2022;28(12):1813–1820. doi: 10.1093/ibd/izac002

[25] Chen B, Zhou B, Song G, et al. Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis. Translational Andrology and Urology. 2022;11(7):959–973. doi: 10.21037/tau-22-190

[26] Chen B., Zhou B., Song G., et al. Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis // Translational Andrology and Urology. 2022. Vol. 11, N 7. P. 959–973. doi: 10.21037/tau-22-190

[27] Chen B, Zhou B, Song G, et al. Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis. Translational Andrology and Urology. 2022;11(7):959–973. doi: 10.21037/tau-22-190

[28] Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technology Assessment. 1998;2(3):I–IV. doi: 10.3310/hta2030

[29] Murphy M.K., Black N.A., Lamping D.L., et al. Consensus development methods, and their use in clinical guideline development // Health Technol Assess. 1998. Vol. 2, N 3. P. I–IV. doi: 10.3310/hta2030

[30] Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technology Assessment. 1998;2(3):I–IV. doi: 10.3310/hta2030

[31] Williams PL, Webb C. The Delphi technique: a methodological discussion. Journal of Advanced Nursing. 1994;19(1):180–186. doi: 10.1111/j.1365-2648.1994.tb01066.x

[32] Williams P.L., Webb C. The Delphi technique: a methodological discussion // Journal of Advanced Nursing. 1994. Vol. 19, N 1. P. 180–186. doi: 10.1111/j.1365-2648.1994.tb01066.x

[33] Williams PL, Webb C. The Delphi technique: a methodological discussion. Journal of Advanced Nursing. 1994;19(1):180–186. doi: 10.1111/j.1365-2648.1994.tb01066.x

[34] Wilhelm W. Alchemy of the Oracle: the Delphi technique. The Delta Pi Epsilon Journal. 2001;43:6–26.

[35] Wilhelm W. Alchemy of the Oracle: the Delphi technique // The Delta Pi Epsilon Journal. 2001. Vol. 43. P. 6–26.

[36] Wilhelm W. Alchemy of the Oracle: the Delphi technique. The Delta Pi Epsilon Journal. 2001;43:6–26.

[37] Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Medical Research Methodology. 2005;5(1). doi: 10.1186/1471-2288-5-37

[38] Akins R.B., Tolson H., Cole B.R. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion // BMC Medical Research Methodology. 2005. Vol. 5, N 1. doi: 10.1186/1471-2288-5-37

[39] Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Medical Research Methodology. 2005;5(1). doi: 10.1186/1471-2288-5-37

[40] Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies. Journal of Clinical Epidemiology. 2014;67(4):401–409. doi: 10.1016/j.jclinepi.2013.12.002

[41] Diamond I.R., Grant R.C., Feldman B.M., et al. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies // Journal of Clinical Epidemiology. 2014. Vol. 67, N 4. P. 401–409. doi: 10.1016/j.jclinepi.2013.12.002

[42] Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies. Journal of Clinical Epidemiology. 2014;67(4):401–409. doi: 10.1016/j.jclinepi.2013.12.002

[43] Andel EM, Koopmann BDM, Crouwel F, et al. Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure? Journal of Crohn’s and Colitis. 2020;14(9):1299–1315. doi: 10.1093/ecco-jcc/jjaa057

[44] Andel E.M., Koopmann B.D.M., Crouwel F., et al. Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure? // Journal of Crohn’s and Colitis. 2020. Vol. 14, N 9. P. 1299–1315. doi: 10.1093/ecco-jcc/jjaa057

[45] Andel EM, Koopmann BDM, Crouwel F, et al. Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure? Journal of Crohn’s and Colitis. 2020;14(9):1299–1315. doi: 10.1093/ecco-jcc/jjaa057

[46] Barberio B, Zamani M, Black CJ, et al. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2021;6(5):359–370. doi: 10.1016/s2468-1253(21)00014-5

[47] Barberio B., Zamani M., Black C.J., et al. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis // The Lancet Gastroenterology & Hepatology. 2021. Vol. 6, N 5. P. 359–370. doi: 10.1016/s2468-1253(21)00014-5

[48] Barberio B, Zamani M, Black CJ, et al. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2021;6(5):359–370. doi: 10.1016/s2468-1253(21)00014-5

[49] Halpin SJ, Ford AC. Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 2012;107(10):1474–1482. doi: 10.1038/ajg.2012.260

[50] Halpin S.J., Ford A.C. Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis // American Journal of Gastroenterology. 2012. Vol. 107, N 10. P. 1474–1482. doi: 10.1038/ajg.2012.260

[51] Halpin SJ, Ford AC. Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 2012;107(10):1474–1482. doi: 10.1038/ajg.2012.260

[52] Yu N, Basnayake C, Connell W, et al. Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases. 2022;28(8):1177–1188. doi: 10.1093/ibd/izab247

[53] Yu N., Basnayake C., Connell W., et al. Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review // Inflammatory Bowel Diseases. 2022. Vol. 28, N 8. P. 1177–1188. doi: 10.1093/ibd/izab247

[54] Yu N, Basnayake C, Connell W, et al. Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases. 2022;28(8):1177–1188. doi: 10.1093/ibd/izab247

[55] Vinogradova IA, Nizovtsova LA, Omelyanskaya OV. Innovative strategic session in the scientific activity of the Center for Diagnostics and Telemedicine. Digital Diagnostics. 2023;3(4):414–420. (In Russ) doi: 10.17816/DD111833

[56] Виноградова И.А., Низовцова Л.А., Омелянская О.В. Инновационная стратегическая сессия в научной деятельности Центра диагностики и телемедицины // Digital Diagnostics. 2023. Т. 3. № 4. С. 414–420. doi: 10.17816/DD111833

[57] Vinogradova IA, Nizovtsova LA, Omelyanskaya OV. Innovative strategic session in the scientific activity of the Center for Diagnostics and Telemedicine. Digital Diagnostics. 2023;3(4):414–420. (In Russ) doi: 10.17816/DD111833

Funding

Департамент здравоохранения города МосквыMoscow Healthcare DepartmentMoscow Healthcare Department(123031400008-4)

RIGHTS & PERMISSIONS

Eco-Vector